Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$169.95M
Total Bought:
$25.62M
Total Sold:
$28.36M
Net Transaction:
-$2.74M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
270,000270,0000$27.19M$27.19M16.00%+$2.7K
Instil Bio, Inc.(TIL)391,103335,000-56,103$4.02M$22.55M13.27%+$18.53M
Atea Pharmaceuticals, Inc.(AVIR)6,375,6216,650,000+274,379$21.10M$22.28M13.11%+$1.17M
Aclaris Therapeutics, Inc.(ACRS)12,988,13414,250,000+1,261,866$14.29M$16.39M9.64%+$2.10M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
200,000175,000-25,000$18.36M$16.07M9.45%-$2.29M
Adverum Biotechnologies Inc1,966,0002,268,064+302,064$13.49M$15.92M9.37%+$2.44M
Tectonic Therapeutic, Inc.(TECX)466,047211,752-254,295$7.68M$6.42M3.78%-$1.26M
An2 Therapeutics Inc05,749,432+5,749,432$0$6.15M3.62%+$6.15M
Reneo Pharmaceuticals Inc2,672,1943,457,395+785,201$4.04M$5.88M3.46%+$1.84M
Oramed Pharmaceuticals Inc.(ORMP)1,349,0382,186,191+837,153$3.47M$5.33M3.14%+$1.87M
Achilles Therapeutics PlcADS625,1744,100,002+3,474,828$509.5K$4.18M2.46%+$3.67M
Whitehawk Therapeutics, Inc.(WHWK)02,000,000+2,000,000$0$4.12M2.42%+$4.12M
Connect Biopharma Hldgs LtdADS2,043,2482,093,232+49,984$3.11M$3.01M1.77%-$91.7K
PMV Pharmaceuticals, Inc.(PMVP)1,309,3971,688,772+379,375$2.12M$2.52M1.48%+$395.0K
Astrotech Corp220,410220,4100$1.96M$1.76M1.04%-$200.6K
Milestone Pharmaceuticals Inc.(MIST)1,102,8951,136,091+33,196$1.46M$1.73M1.02%+$271.0K
LENZ Therapeutics, Inc.(LENZ)63,91660,000-3,916$1.11M$1.42M0.84%+$319.3K
Ikena Oncology Inc585,114723,288+138,174$965.4K$1.25M0.74%+$285.9K
Vanda Pharmaceuticals Inc.(VNDA)398,280228,500-169,780$2.25M$1.07M0.63%-$1.18M
Lisata Therapeutics, Inc.(LSTA)284,669284,6690$987.8K$854.0K0.50%-$133.8K
Pieris Pharmaceuticals Inc042,130+42,130$0$698.5K0.41%+$698.5K
CalciMedica, Inc.(CALC)160,424153,887-6,537$635.3K$681.7K0.40%+$46.4K
Allovir Inc603,086603,0860$436.2K$487.6K0.29%+$51.4K
Talis Biomedical Corp42,743248,702+205,959$370.2K$460.1K0.27%+$89.9K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$522.0K$451.5K0.27%-$70.5K
Forte Biosciences Inc070,468+70,468$0$393.9K0.23%+$393.9K
Nextcure Inc276,465276,4650$439.6K$378.8K0.22%-$60.8K
Verrica Pharmaceuticals Inc.(VRCA)180,000180,0000$1.31M$261.0K0.15%-$1.05M
Hillevax Inc019,760+19,760$0$34.8K0.02%+$34.8K
Athira Pharma Inc900,0000-900,000$2.38M$0—-$2.38M
Design Therapeutics, Inc.(DSGN)421,7490-421,749$1.41M$0—-$1.41M
Forte Biosciences Inc1,761,7020-1,761,702$946.0K$0—-$946.0K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q3 2024 | TickerTrail